Every retinoid sits on one pathway — retinyl esters → retinol → retinaldehyde → retinoic acid — and only retinoic acid is active at the skin's receptors. That single fact draws the legal line through the category. Forms that must be converted by the skin are sold as cosmetics; forms that are already receptor-active are regulated as medicines. It is not a difference of strength alone — it determines what a product may legally claim. And the classification is jurisdictional: adapalene is sold over the counter in the United States and requires a prescription elsewhere, which means the same molecule can be a cosmetic in one country and a drug in another.
| Question | In brief |
|---|---|
| What is a retinoid? | Any vitamin A derivative on the retinyl ester → retinol → retinal → retinoic acid pathway. |
| Which form is active? | Only retinoic acid binds the skin's retinoic acid receptors. Everything else must convert to it. |
| What makes one a medicine? | Receptor activity plus intended use plus jurisdiction — see the Jurisdiction Test below. |
| Retinol vs retinaldehyde? | Retinal is one conversion step closer to retinoic acid, so generally more potent among cosmetic forms. |
| Is retinol banned in the EU? | No. Capped at 0.3% retinol equivalent (face/hand) and 0.05% (body) under Regulation (EU) 2024/996.1 |
| Why the EU cap? | To manage total vitamin A intake across diet, supplements and cosmetics. The SCCS concluded cosmetic retinol is safe.2 |
| What applies in India? | Tretinoin is a prescription medicine. Retinol is a cosmetic under the Cosmetics Rules 2020 — see the India section. |
- All retinoids share one pathway; only retinoic acid is receptor-active, and cosmetic forms must convert to it in the skin.
- Retinaldehyde is one step from retinoic acid, retinol is two, retinyl esters are three — that ordering is the whole potency hierarchy.
- The cosmetic/medicine line is set by receptor activity, intended use and jurisdiction — not by the molecule alone.
- The EU caps cosmetic retinol at 0.3% RE (face) / 0.05% RE (body) under Regulation (EU) 2024/996 — an intake-management measure, not a safety ban.1,2
- Compliance deadlines: new products from 1 November 2025, non-compliant stock off market by 1 May 2027.1
- In India, a cosmetic retinol product must keep claims to appearance — "treats acne" or "boosts collagen" are medicinal claims a cosmetic cannot make.
Section 01
What Does "Retinoid" Actually Mean?
"Retinoid" is a family name, not an ingredient. It covers vitamin A and everything derived from it — the forms your body makes and the forms manufactured for skincare and medicine. Arguing about "retinol versus retinoids" is a category error, roughly like comparing espresso with coffee.
What unites the family is a single destination. Skin responds to vitamin A in exactly one form — retinoic acid — because that is the form that binds retinoic acid receptors and alters gene expression in the cell.6 Every other retinoid is a precursor the skin must convert. The number of conversion steps is the most useful thing to know about any retinoid, because it predicts potency, irritation and — as the next sections show — legal status.
Section 02
The Conversion Cascade
Vitamin A moves along a one-directional pathway inside the skin, each step converting one form into the next:
retinyl esters → retinol → retinaldehyde → retinoic acid
Two rules follow, and between them they explain nearly every practical difference between products.
Rule one: fewer conversions means more potency. Retinyl esters sit three steps out. Retinol is two.6 Retinaldehyde is one. Retinoic acid is already there, which is precisely why it is prescription-only. Retinoic acid is approximately 20 times more potent than retinol.6
Rule two: potency and irritation rise together. The same receptor activity that drives the visible effect drives the dryness and flaking. This is why the strongest option is rarely the right option — a tolerable retinoid used for a year beats a potent one abandoned in a fortnight.
Section 03
The Jurisdiction Test: Cosmetic Or Medicine?
The usual explanation is that strong retinoids are drugs and weak ones are cosmetics. That is roughly right and it misses the interesting part — because the same molecule can be classified differently in different countries.
Three things determine which side of the line a retinoid falls on.
Because intended use is a legal determinant, the claims on a bottle tell you something real about the product's classification. A cosmetic that says it "treats acne" or "boosts collagen synthesis" is either making a claim it cannot support in law, or is a medicine sold as a cosmetic. Neither is a good sign. A brand that keeps its language to appearance is not being coy — it is being accurate.
"Over-the-counter retinol does the same thing as prescription tretinoin, just in a weaker bottle."
They sit on the same pathway, but tretinoin is retinoic acid — receptor-active on contact — while retinol requires two enzymatic conversions in the skin, and retinoic acid is roughly 20× the potency of retinol.6 They differ in strength, in regulation, and in what each may legally claim.
Section 04
The Cosmetic Retinoids
These are the forms in serums and creams. All rely on the skin's own conversion machinery.
Retinyl esters (retinyl palmitate, retinyl acetate)
Three steps from retinoic acid and the mildest by a distance. Suitable for very reactive skin or a first exposure, with the trade-off that very little arrives as retinoic acid. If an ingredient list shows a retinyl ester near the bottom, treat it as a gesture rather than a dose.
Retinol
The category reference point and the form with the deepest real-world track record. Two conversions, typically supplied between 0.025% and 1%, and more stable in formulation than retinaldehyde.
Retinaldehyde (retinal)
One step out, and generally regarded as substantially more potent than retinol at equal concentration. It also has a property retinol does not: retinaldehyde shows direct antibacterial activity against Cutibacterium acnes, which retinol and retinoic acid do not share.7 The trade-off is stability — it oxidises readily and needs airless, opaque packaging.
Newer derivatives (hydroxypinacolone retinoate)
Marketed as receptor-interacting with a gentler tolerability profile. Often positioned for sensitive skin, though the independent long-term evidence base is considerably smaller than retinol's — which is worth weighing against the marketing.
| Form | Steps to acid | Status | Relative strength* | Notes |
|---|---|---|---|---|
| Retinyl esters | 3 | Cosmetic | Mildest | Gentlest and slowest; least arrives as active. |
| Retinol | 2 | Cosmetic | Baseline (1×) | Category reference point; most stable of the cosmetic forms. |
| Retinaldehyde | 1 | Cosmetic | Higher | Antibacterial against C. acnes;7 needs airless packaging. |
| Hydroxypinacolone retinoate | Receptor-interacting | Cosmetic | Varies | Smaller independent evidence base. |
| Adapalene | 0 — synthetic | Varies by market8 | High | OTC at 0.1% in the US; prescription in many markets. |
| Tretinoin | 0 — is retinoic acid | Prescription | ~20× retinol6 | A medicine, not a cosmetic. |
| Tazarotene | 0 — synthetic | Prescription | Very high | Receptor-active synthetic; a medicine. |
*A general ordering for context, not a clinical equivalence chart. Real-world results depend on concentration, formulation, frequency and individual skin.
Section 05
The Prescription Retinoids
Prescription retinoids are either retinoic acid itself or synthetic molecules acting directly at its receptors, so they skip the cascade entirely. Tretinoin (all-trans retinoic acid) is the long-established example, with foundational photoageing work dating to the 1980s.9 Tazarotene and trifarotene are synthetic receptor-active retinoids. Adapalene is the boundary case described above.
These are medicines. Decisions about whether to use one, at what strength, and how to combine it with the rest of a routine belong with a prescriber or dermatologist. This article describes the category for context and is not a recommendation to start, stop or substitute any prescription treatment.
Section 06
The EU Retinol Limits, Explained
In April 2024 the European Commission adopted Commission Regulation (EU) 2024/996, amending Annex III of Regulation (EC) No 1223/2009 and setting maximum concentrations for three vitamin A forms in cosmetics: retinol, retinyl acetate and retinyl palmitate.1
| Product type | Maximum (retinol equivalent) | Compliance date |
|---|---|---|
| Face and hand products | 0.3% RE | New products from 1 Nov 2025 |
| Body lotions | 0.05% RE | Non-compliant off market by 1 May 2027 |
Products must carry the wording "Contains Vitamin A. Consider your daily intake before use." The limits are expressed as retinol equivalent because the esters convert to retinol in the body, so all three are measured on a common scale.1
"The EU restricted retinol because it turned out to be unsafe for skin."
The Scientific Committee on Consumer Safety concluded that cosmetic retinol is safe.2 The limit manages total vitamin A intake across diet, supplements and cosmetics combined, because a minority of the population already approaches the recommended upper intake from food and supplements alone. It is an exposure-management measure across all sources, not a finding about skin.
This distinction is worth holding onto, because it recurs across cosmetic regulation: a concentration limit is a margin-of-safety tool, not a danger signal. Reading every restriction as evidence of harm produces a badly calibrated picture of ingredient safety.
Section 07
What Applies In India?
Almost every article on retinoid regulation is written for EU or US readers. If you are buying in India, three things are worth knowing.
Tretinoin is a prescription medicine. It is regulated as a drug under India's Drugs and Cosmetics framework, not as a cosmetic, and requires a prescription. The same applies to other receptor-active prescription retinoids.
Retinol is a cosmetic. Cosmetic products in India fall under the Cosmetics Rules, 2020, administered by CDSCO. Retinol, retinaldehyde and retinyl esters are used in cosmetics on that basis.
India has not adopted the EU's concentration cap. The 0.3% / 0.05% retinol-equivalent limits are an EU measure under Regulation (EU) 2024/996 and do not automatically apply here. A product sold in India is not bound by the EU numbers — which cuts both ways: it means higher-concentration products are legal, and it means the EU cap is not a benchmark you can assume a product has met.
Section 08
What A Cosmetic Retinoid May Legally Claim
This is where the cosmetic/medicine line becomes something you can actually see on a label — and it is the most practical use of everything above.
A cosmetic is sold to affect the appearance of skin. A medicine treats disease or alters structure and function.4 EU rules on cosmetic claims state plainly that a cosmetic must not be presented as having medicinal or pharmacological properties,11 and India's framework under the Cosmetics Rules 2020 and the ASCI Code draws the same distinction.
| Cosmetic claim (permissible) | Medicinal claim (not permissible for a cosmetic) |
|---|---|
| Supports the appearance of fine lines | Reverses ageing |
| Smoother-looking texture | Boosts collagen synthesis |
| More even-looking tone | Treats hyperpigmentation |
| Supports the look of clearer skin | Treats acne |
| Helps skin feel comfortable | Repairs the skin barrier |
The right-hand column is not merely stricter phrasing — those claims assert an effect on structure or function, which is what a medicine does. A cosmetic making them is either overclaiming or misclassified.
Section 09
Safety, Sensitive Skin And Pregnancy
Pregnancy and breastfeeding. Oral retinoids such as isotretinoin are established teratogens and are strictly contraindicated in pregnancy. Topical exposure is far lower, but standard medical advice is to avoid both topical and oral retinoids during pregnancy and breastfeeding as a precaution.10 This applies to over-the-counter retinol as well as prescription products. If you are pregnant, trying to conceive or breastfeeding, consult your doctor before using any retinoid.
Sensitive or compromised skin. Eczema, rosacea, psoriasis or an already-impaired barrier all raise the likelihood of irritation. Gentler forms, lower frequency and barrier support help; a dermatologist can advise on suitability. These are medical conditions, and nothing here constitutes treatment advice for them.
Getting started without wrecking your barrier. The short version: start low, twice weekly, apply to dry skin rather than damp, moisturise after, never skip morning SPF, and add one active at a time. The full ramp schedule, buffering methods and what to do when retinisation gets uncomfortable are covered in our companion guide to retinoid types, strengths and how to start.
SkinReset™ PDRN Serum
The recurring point above is that a retinoid you tolerate beats a stronger one you abandon — and tolerance is largely a barrier question. Water loss rises when turnover outpaces the lipid matrix, which is what the uncomfortable weeks actually consist of.
SkinReset™ uses a dual-encapsulation delivery system, part nanoliposomal for immediate release and part polymeric for sustained release. It is the Boldpurity formula with instrumental barrier data behind it.
In-vivo study SKIN-BPAG-2025-01, MS Clinical Research Bangalore, IEC-ACE ethics approval. N=30 completers, 8 weeks, Fitzpatrick III–V. Endpoints shown reached statistical significance; not all measured endpoints did. Full study details.
Stated plainly: this study did not test SkinReset alongside a retinoid, and no claim is made that it reduces retinisation. What it measured is water loss and hydration — the two parameters that move in the wrong direction while skin adjusts.
View SkinReset™Frequently Asked Questions
What is the difference between retinol and retinoids?
"Retinoid" is the umbrella term for all vitamin A derivatives; retinol is one specific cosmetic retinoid within that family. So retinol is a retinoid, but not all retinoids are retinol. The family also includes retinyl esters, retinaldehyde, and the prescription forms such as tretinoin and tazarotene.
What makes a retinoid a medicine rather than a cosmetic?
Three things together: whether it is receptor-active without conversion, what it is intended to do, and which country you are in. Tretinoin is retinoic acid itself and is a medicine everywhere. Adapalene is sold over the counter in the United States and requires a prescription in many other markets — the same molecule at the same concentration, classified differently. Regulatory status is not purely a property of the chemistry.
Is retinol banned in the EU?
No. Under Commission Regulation (EU) 2024/996, cosmetic retinol, retinyl acetate and retinyl palmitate are limited to 0.3% retinol equivalent in face and hand products and 0.05% in body lotions, with mandatory vitamin A labelling. The Scientific Committee on Consumer Safety concluded cosmetic retinol is safe; the limit manages total vitamin A intake across all sources.
Does the EU retinol limit apply in India?
No. The 0.3% and 0.05% caps are an EU measure under Regulation (EU) 2024/996 and do not automatically apply to products sold in India, where cosmetics fall under the Cosmetics Rules 2020 administered by CDSCO. That means higher-concentration retinol products can be sold legally in India, and it also means you cannot assume a product has met the EU threshold.
Is over-the-counter retinol the same as prescription tretinoin?
No. Tretinoin is retinoic acid, receptor-active on contact, and roughly twenty times the potency of retinol. Over-the-counter retinol must be converted by the skin through two enzymatic steps. They differ in strength, in how they are regulated, and in what each is legally permitted to claim.
Is retinaldehyde stronger than retinol?
Generally yes. Retinaldehyde is one conversion step from retinoic acid where retinol is two, which makes it substantially more potent at equal concentration. It also has direct antibacterial activity against Cutibacterium acnes that retinol does not share. The trade-off is stability — retinaldehyde oxidises readily and needs airless, opaque packaging.
Can I use retinoids during pregnancy?
Standard medical advice is to avoid both topical and oral retinoids during pregnancy, while trying to conceive, and while breastfeeding. Oral retinoids are established teratogens; topical exposure is far lower but caution is still advised. This applies to over-the-counter retinol as well as prescription products. Consult your doctor about alternatives.
Why can't a retinol product say it treats acne?
Because treating a condition is what a medicine does. A cosmetic is legally defined by its effect on the appearance of skin, so claims like "treats acne," "boosts collagen synthesis" or "repairs the barrier" assert an effect on structure or function that places a product on the medicine side of the line. A cosmetic making those claims is either overclaiming or misclassified.
Which retinoid should a beginner start with?
Most people do well starting with retinol at a low concentration, twice weekly, and building up over several weeks. Very reactive skin can begin with a retinyl ester. Percentages are only comparable within a form, so a low retinol is not directly comparable to a low retinaldehyde. Tolerance built slowly matters more than the form you choose.
What is the strongest retinoid?
Among topical retinoids, the prescription receptor-active forms — tretinoin and tazarotene — are the most potent, because they require no conversion. Retinoic acid is approximately twenty times more potent than retinol. Among cosmetic forms, retinaldehyde is the strongest, sitting one conversion step from the active form.
References
- European Commission. Commission Regulation (EU) 2024/996 of 3 April 2024 amending Regulation (EC) No 1223/2009 as regards the use of Vitamin A, Alpha-Arbutin and Arbutin and certain substances with potential endocrine-disrupting properties in cosmetic products. eur-lex.europa.eu/eli/reg/2024/996
- Scientific Committee on Consumer Safety (SCCS). Opinion on Vitamin A (Retinol, Retinyl Acetate, Retinyl Palmitate), SCCS/1634/21. European Commission.
- European Parliament and Council. Regulation (EC) No 1223/2009 on cosmetic products (Annex III; Article 20 on claims). eur-lex.europa.eu
- US Food and Drug Administration. "Is It a Cosmetic, a Drug, or Both? (How to Tell)" — classification under the Federal Food, Drug, and Cosmetic Act. fda.gov/cosmetics
- Mukherjee S, Date A, Patravale V, et al. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clinical Interventions in Aging. 2006;1(4):327–348.
- Zasada M, Budzisz E. Retinoids: active molecules influencing skin structure formation in cosmetic and dermatological treatments. Postępy Dermatologii i Alergologii. 2019;36(4):392–397.
- Pechère M, Germanier L, Siegenthaler G, Pechère JC, Saurat JH. The antibacterial activity of topical retinoids: the case of retinaldehyde. Dermatology. 2002;205(2):153–158.
- US Food and Drug Administration. FDA approves Differin Gel 0.1% (adapalene) for over-the-counter use (2016) — first OTC topical retinoid for acne in the US.
- Kligman AM, Grove GL, Hirose R, Leyden JJ. Topical tretinoin for photoaged skin. Journal of the American Academy of Dermatology. 1986;15(4 Pt 2):836–859.
- Dermatological consensus on topical retinoid avoidance in pregnancy as a precaution; oral retinoids are established teratogens. See national prescribing guidance and product labelling.
- European Commission. Commission Regulation (EU) No 655/2013 laying down common criteria for the justification of claims used in relation to cosmetic products. eur-lex.europa.eu
- Government of India, Ministry of Health and Family Welfare. Cosmetics Rules, 2020 (CDSCO); and the ASCI Code for Self-Regulation in Advertising, 2021.
- Boldpurity in-house data: protocol SKIN-BPAG-2025-01, in-vivo study, MS Clinical Research Bangalore, IEC-ACE approved, N=30 completers, 8 weeks, Fitzpatrick III–V.
